Join to View Full Profile
520 Country Club PkwyEugene, OR 97401
Phone+1 541-683-5001
Fax+1 541-683-1422
Dr. Uemura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Marc Uemura, MD, is a board certified hematologist / oncologist based in Eugene, OR. He graduated from the University of California, Irvine, School of Medicine in 2010 and then completed his residency in Internal Medicine at Los Angeles County - Harbor UCLA Medical Center between 2010 and 2013. He was a chief resident at Harbor UCLA from 2013-2014. He then pursued a fellowship in Hematology and Medical Oncology at the University of Texas MD Anderson Cancer Center from 2014 to 2017.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2010 - 2013
University of California, Irvine, School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2011 - Present
OR State Medical License 2017 - 2025
TX State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 33 citationsTilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma.Cara Haymaker, Daniel H. Johnson, Ravi Murthy, Salah-Eddine Bentebibel, Marc Uemura
Cancer Discovery. 2021-01-01 - 58 citationsMolecular profiling of hepatocellular carcinoma using circulating cell-free DNAAhmed Kaseb, Nora S. Sanchez, Shiraj Sen, Robin Kate Kelley, Benjamin R. Tan
Clinical Cancer Research. 2019-10-15 - 66 citationsIL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy.Daniel H. Johnson, Anisha B. Patel, Marc Uemura, Van Anh Trinh, Natalie Jackson
Cancer Immunology Research. 2019-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
